[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.52.237. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editor's Correspondence
December 11/25, 2000

White-Coat Hypertension or White-Coat Hypertension Syndrome: Which Is Accompanied by Target Organ Damage?—Reply

Arch Intern Med. 2000;160(22):3495-3496. doi:

In reply

Drs Kario and Pickering raise several reasonable points. First, they suggest that we could have used a criterion defining normal daytime ambulatory BP of 135/85 mm Hg or lower, rather than 140/90 mm Hg or lower. Regardless of the criterion used, our group with white-coat hypertension had normal ambulatory BP (mean, 129/80 mm Hg), and was carefully matched to normotensive controls (mean ambulatory BP 128/80 mm Hg).

Second, Drs Kario and Pickering would have preferred stricter exclusion of individuals with diabetes. Among our group with white-coat hypertension, 3 participants met current criteria for diabetes, though none were receiving drug therapy, and their mean fasting glucose level was just 7.5 mmol/L (135 mg/dL). As noted in the "Results" section, the mean carotid plaque score of these 3 individuals was identical to that of the rest of the white-coat hypertension group. Thus, the inclusion of mild diabetes did not materially affect our results.

First Page Preview View Large
First page PDF preview
First page PDF preview
×